Affymetrix, Inc.-医療機器分野:企業M&A・提携分析

◆英語タイトル:Affymetrix, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011512
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument systems, namely, GeneChip, GeneTitan and GeneAtlas that include instruments, consumables and software. Its product portfolio consists of microarray solutions, eBioscience immunology reagents, molecular biology kits and reagents, and others. The company has manufacturing facilities in San Diego, Cleveland, Vienna, and Singapore. Its products are widely used by genomic research centers; academic institutions; government and private laboratories; and pharmaceutical, diagnostic, and biotechnology companies across the US, Europe, Latin America, and Asia. Affymetrix is headquartered in Santa Clara, California, the US.

Affymetrix, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Affymetrix, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Affymetrix, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Affymetrix, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Affymetrix, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Affymetrix, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Affymetrix, Inc., Medical Equipment, Deal Details 11
Partnerships 11
Affymetrix Enters into Licensing Agreement with Peptide Groove 11
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 12
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 13
Affymetrix Enters Into Licensing Agreement With Genisphere 14
Affymetrix Enters into Agreement with Reveal Biosciences 15
XRGenomics Enters into Research Agreement with Affymetrix 16
Affymetrix Enters into Distribution Agreement with Luminex 17
Cytox Enters into Joint Development Partnership with Affymetrix 18
Affymetrix Enters Into Integration Agreement With CollabRx 19
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 20
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 21
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 22
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 23
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 24
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 25
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 26
Affymetrix Enters Into Distribution Agreement With Thermo Fisher 27
Equity Offering 28
Affymetrix to Raise USD50 Million in Private Placement of Shares 28
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 29
Debt Offering 30
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 30
Acquisition 32
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 32
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 34
Affymetrix, Inc. – Key Competitors 36
Affymetrix, Inc. – Key Employees 37
Affymetrix, Inc. – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 40
Financial Announcements 40
Feb 17, 2016: Affymetrix Reports Fourth Quarter 2015 Operating Results 40
Product News 42
03/08/2016: Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Affymetrix, Inc., Medical Equipment, Key Facts, 2015 2
Affymetrix, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Affymetrix, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Affymetrix, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Affymetrix, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Affymetrix, Inc., Deals By Market, 2011 to YTD 2017 8
Affymetrix, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Affymetrix Enters into Licensing Agreement with Peptide Groove 11
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 12
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 13
Affymetrix Enters Into Licensing Agreement With Genisphere 14
Affymetrix Enters into Agreement with Reveal Biosciences 15
XRGenomics Enters into Research Agreement with Affymetrix 16
Affymetrix Enters into Distribution Agreement with Luminex 17
Cytox Enters into Joint Development Partnership with Affymetrix 18
Affymetrix Enters Into Integration Agreement With CollabRx 19
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 20
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 21
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 22
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 23
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 24
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 25
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 26
Affymetrix Enters Into Distribution Agreement With Thermo Fisher 27
Affymetrix to Raise USD50 Million in Private Placement of Shares 28
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 29
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 30
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 32
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 34
Affymetrix, Inc., Key Competitors 36
Affymetrix, Inc., Key Employees 37
Affymetrix, Inc., Other Locations 38
Affymetrix, Inc., Subsidiaries 38

★海外企業調査レポート[Affymetrix, Inc.-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solaria Energia y Medio Ambiente S.A. (SLR):電力:M&Aディール及び事業提携情報
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • NRG Energy Inc (NRG)-エネルギー分野:企業M&A・提携分析
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy, and energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related …
  • Viesgo:電力:M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Theravance Biopharma Inc (TBPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company. Its flagship product, Vibativ (telavancin) is a bactericidal, once-daily injectable antibiotic to treat patients with serious, life-threatening infections due to Staphylococcus aureus and other Gram-p …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • Dynapac Co., Ltd.:企業の戦略・SWOT・財務情報
    Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynapac Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vivimed Labs Ltd (VIVIMEDLAB)-製薬・医療分野:企業M&A・提携分析
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Gujarat State Electricity Corporation Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Strides Pharma Science Limited (STAR):医療機器:M&Aディール及び事業提携情報
    Summary Strides Pharma Science Limited (Strides Pharma), formerly Strides Shasun Ltd, is a pharmaceutical company which offers generic products. It focuses on the development and manufacture of intellectual property- led niche pharmaceutical products, over-the-counter drugs and nutraceuticals. The c …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. Suburban Propane also provides installation and service of various types …
  • Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析
    Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aragen Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process d …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆